Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Pliant Therapeutics Inc. Stock

Price
Target price
€1.18

€1.18

-4.840%
-0.06
-4.840%
-
 
13.06.25 / Stuttgart Stock Exchange WKN: A2P4YV / Name: Pliant Therapeutics Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction
Pros and Cons of Pliant Therapeutics Inc. in the next few years
Wizard

Pliant Therapeutics Inc. Stock

Heavy losses for Pliant Therapeutics Inc. today as the stock fell by -€0.060 (-4.840%).
For the coming years our community has positive and negative things to say abot the Pliant Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Business model" there were negative voices in the community.
What does Pliant Therapeutics Inc. do?

Pros and Cons of Pliant Therapeutics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Pliant Therapeutics Inc. presents a complex financial narrative that demands a nuanced examination. While the company operates in the evolving biotechnology sector, its financial metrics reveal both potential and challenges. The overall impression is that Pliant Therapeutics is navigating a path marked by high expectations but tempered by substantial hurdles. Evaluating the financials sheds light on its viability and growth prospects.

*Pros: *

Innovative Sector Exposure: Pliant operates in a promising niche of biotechnology, particularly focusing on fibrotic diseases. This specialization can be a significant advantage as the demand for novel therapies continues to rise in the healthcare market. The innovation-driven nature of the sector could create opportunities for substantial revenue growth in the future.

Show more
Register To Post